Lisata Therapeutics, Inc. (LSTA)
3.23
-0.14
(-4.15%)
USD |
NASDAQ |
Apr 17, 16:00
3.49
+0.26
(+8.05%)
Pre-Market: 08:22
Lisata Therapeutics SG&A Expense (Quarterly) : 2.045M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Penumbra, Inc. | 181.10M |
| Protalix Biotherapeutics, Inc. | 3.526M |
| PAVmed, Inc. | 4.942M |
| Agenus, Inc. | 12.30M |
| Curis, Inc. | 2.883M |